What does Evopoint Biosciences Co. Ltd. do?

Evopoint Biosciences Co. Ltd. (688837.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 688837.SS's market cap?

Evopoint Biosciences Co. Ltd. (688837.SS) has a market capitalization of approximately ¥19.62 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

Does 688837.SS pay a dividend?

No, Evopoint Biosciences Co. Ltd. (688837.SS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

688837.SS (Evopoint Biosciences Co. Ltd.) is a recent IPO.

It began trading on September 16, 2026, giving it a few months of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates. The affected sections are flagged individually so you can tell limited history from missing data.

688837.SS

Evopoint Biosciences Co. Ltd.

SHH·Biotechnology · Healthcare

¥39.19¥1.48+3.92%

Market cap¥19.62B·Market closed·Oct 23 3:00 AM EDT

Price Chart

¥39.19+¥1.48 (+3.92%)today

−2.46%

Select date range

FromTo

Sep 16, 2026Sep 16, 2026 → Oct 24, 2026· 38 daysOct 24, 2026

Key Metrics

688837.SS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how 688837.SS's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688837.SS and 80,000+ other tickers.

About Evopoint Biosciences Co. Ltd.

Evopoint Biosciences Co., Ltd. operates as a biopharmaceutical company that offers therapies for patients with oncology and multidrug-resistant infections. The company's three core technology platforms are a Small Molecule Drug Discovery Platform, a Novel Antibody Discovery Platform, and a Targeted Protein Degradation Platform. Several of its pipeline products have advanced to Phase III clinical trials or the New Drug Application stage.

CEO: Mei Jie Le
Sector: Healthcare
Industry: Biotechnology
Exchange: SHH
Employees: 362
Website: www.evopointbio.com

Peers

Peers Tab

688321.SS

Shenzhen Chipscreen Biosciences Co., Ltd.

Cap

¥10.0B

688331.SS

RemeGen Co. Ltd. Class A

Cap

¥56.7B

688578.SS

Shanghai Allist Pharmaceuticals Co., Ltd.

Cap

¥39.7B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688837.SS

What does Evopoint Biosciences Co. Ltd. do?: Evopoint Biosciences Co. Ltd. (688837.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688837.SS's market cap?: Evopoint Biosciences Co. Ltd. (688837.SS) has a market capitalization of approximately ¥19.62 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.
Does 688837.SS pay a dividend?: No, Evopoint Biosciences Co. Ltd. (688837.SS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.